| Nov 3 2018 |
EPA Extends Dicamba Products Registered for “Over-the-Top” Use |
Bergeson & Campbell, P.C. |
| Nov 2 2018 |
OIG Report on Topical Compounded Drug Prescribing, Marketing and Billing Practices Signals Heightened Administrative and Enforcement Scrutiny |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 2 2018 |
FDA Releases Statement On A New Plant And Animal Biotechnology Innovation Action Plan |
Bergeson & Campbell, P.C. |
| Nov 2 2018 |
FDA Announces Release of Environmental Assessment for E. Coli Outbreak Associated with Romaine Lettuce |
Keller and Heckman LLP |
| Nov 1 2018 |
A Glimpse of Things to Come: OSHA’s Soon to Be Updated Hazard Communication Standard |
Bergeson & Campbell, P.C. |
| Nov 1 2018 |
United Airlines Faces Multiple Food Safety Whistleblower Lawsuits |
Keller and Heckman LLP |
| Nov 1 2018 |
Navigating Canada’s New Cannabis Law—Don’t Let an Employee’s Immigration Status Go Up in Smoke |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 31 2018 |
Cases Addressing Employee Protections Under Marijuana Laws Remain Inconsistent |
Steptoe & Johnson PLLC |
| Oct 31 2018 |
FDA Announces Plant and Animal Biotechnology Innovation Action Plan |
Keller and Heckman LLP |
| Oct 31 2018 |
UK to Impose a New Tax on Plastic Packaging |
Keller and Heckman LLP |
| Oct 30 2018 |
FDA Considering Labeling for Sesame Allergies |
Keller and Heckman LLP |
| Oct 29 2018 |
CMS Requests Comment on Potential International Pricing Index Model for Part B Drugs |
McDermott Will & Schulte LLP |
| Oct 29 2018 |
Two Food Safety Modernization Act Draft Guidance Documents Issued by FDA for Farmers, Food Processors |
Barnes & Thornburg LLP |
| Oct 29 2018 |
Trump Administration Proposes to Lower Drug Prices Through Medicare Part B |
Mintz |
| Oct 29 2018 |
Knowledge Is Not Power for Class Action Plaintiffs |
Bilzin Sumberg |
| Oct 29 2018 |
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model |
Epstein Becker & Green, P.C. |
| Oct 29 2018 |
FDA Will Hold Public Meetings Throughout the U.S. in November and December for Discussion of the New Draft Guidance on Standards for Compliance with the Produce Safety Rule |
Keller and Heckman LLP |
| Oct 26 2018 |
OIRA Seeks Comment on How to Reduce Regulatory Differences between the U.S. and Canada, Including for Emerging Technologies Not Yet Regulated |
Bergeson & Campbell, P.C. |
| Oct 26 2018 |
McDermott's Plus Check-up: October 26, 2018 |
McDermott Will & Schulte LLP |
| Oct 26 2018 |
Price Fixing in the Food Industry |
Bilzin Sumberg |
| Oct 26 2018 |
Final Comments Received Regarding FDA’s Nutrition Innovation Strategy |
Keller and Heckman LLP |
| Oct 26 2018 |
Ninth Circuit Orders Ban on Chlorpyrifos |
Squire Patton Boggs (US) LLP |
| Oct 25 2018 |
Top International News in Chemical Policy and Regulation: October 25, 2018: OECD, Asia, Americas and Middle East |
Bergeson & Campbell, P.C. |
| Oct 25 2018 |
Top International News in Chemical Policy and Regulation: October 25, 2018: European Union and United Kingdom |
Bergeson & Campbell, P.C. |
| Oct 25 2018 |
Proposed Amendments to Proposition 65 Regulations on Calculating Level of Exposure to Chemicals Causing Reproductive Toxicity; California Extends Comment Period |
Keller and Heckman LLP |
| Oct 25 2018 |
New Handbook Provides Guidance to Healthcare Delivery Organizations on Preparation and Response to Medical Device Cybersecurity Incidents |
Faegre Drinker |
| Oct 25 2018 |
The Feds and New York Allow Further Access to CBD and Medical Cannabis |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Oct 25 2018 |
President Signs New Law Allowing Telemedicine Prescribing of Controlled Substances: DEA Special Registration to Go Live |
Foley & Lardner LLP |
| Oct 24 2018 |
New NJ Bill Aims to End Craft Brewery Tours & Add Food Vendors |
Stark & Stark |
| Oct 24 2018 |
FDA Emphasizes Continued Commitment to Develop a Strong Tobacco Product Application Review Process |
Keller and Heckman LLP |
| Oct 23 2018 |
WV Opioid Reduction Act Imposes New Restrictions and Responsibilities on Prescribers |
Steptoe & Johnson PLLC |
| Oct 23 2018 |
Six Initiatives States May Pursue to Curb Drug Prices and the 340B Factor |
Mintz |
| Oct 23 2018 |
China Announces Draft and Final Approvals for Food-Contact Materials |
Keller and Heckman LLP |
| Oct 23 2018 |
CMS Unveils Proposed Rule Regarding Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products |
Epstein Becker & Green, P.C. |
| Oct 23 2018 |
FDA Issues Draft Guidance on Produce Safety Requirements under FSMA |
Keller and Heckman LLP |
